Illumina, Inc. (ILMN): Depreciation & Amortization
$270.00M
Year ended 2025-12-28
-11.8%
3-year compound annual growth
+7.6%
5-year compound annual growth
+7.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $270.00M | -23.7% | 2026-02-12, From 2024-12-30 |
| 2024-12-29 | $354.00M | -18.1% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $432.00M | +9.6% | 2026-02-12, From 2023-01-02 |
| 2023-01-01, Fiscal 2022 | $394.00M | +57.0% | 2025-02-12, From 2022-01-03 |
| 2022-01-02, Fiscal 2021 | $251.00M | +34.2% | 2024-02-16, From 2021-01-04 |
| 2021-01-03, Fiscal 2020 | $187.00M | -0.5% | 2023-02-17, From 2019-12-30 |
| 2019-12-29 | $188.00M | +5.0% | 2022-02-18, From 2018-12-31 |
| 2018-12-30 | $179.00M | +14.7% | 2021-02-17, From 2018-01-01 |
| 2017-12-31 | $156.00M | +10.6% | 2020-02-11, From 2017-01-02 |
| 2017-01-01, Fiscal 2016 | $141.00M | +11.0% | 2019-02-12, From 2016-01-04 |
| 2016-01-03, Fiscal 2015 | $127.00M | +12.8% | 2018-02-13, From 2014-12-29 |
| 2014-12-28 | $112.57M | n/a | 2017-02-14, From 2013-12-30 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Illumina, Inc. (ILMN) | 2025-12-28 | $270.00M | -23.7% |
| Bruker Corp (BRKR) | 2025-12-31 | $220.30M | +19.9% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $410.20M | +1.2% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $405.34M | -5.3% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $288.00M | +12.1% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $165.40M | +9.1% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $36.20M | +0.9% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $7.58M | +5.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $15.84M | +145.1% |
Compare ILMN, BRKR, AVTR, RVTY side by side · Screen every company in Laboratory Analytical Instruments ↗